Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

946986

	registered interest
	date	23/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what guidance his Department issues to help people better understand their diabetes.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	167325
	answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>'Healthier You: The NHS Diabetes Prevention Programme' started in 2016 and currently covers three quarters of the population of England. At the end of May 2018, nearly 215,000 people had been referred into the service, with over 95,000 taking up the offer of a programme.</p><p>By 2020, the programme will support 100,000 people at risk of diabetes each year across England. Those referred will get tailored, personalised help to reduce their risk including education on healthy eating and lifestyle and bespoke physical exercise programmes.</p><p>NHS England has invested £10.5 million transformation funding in 2018/19 (and a similar amount in 2017/18) to provide approximately 96,000 additional structured education places in 137 clinical commissioning groups.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 16:50:07 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

997157

	registered interest
	date	29/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many hospital trusts (a) collect and (b) submit data on the number of people diagnosed with secondary breast cancer to the cancer outcomes and services data set.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	184978
	answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>140 hospital trusts submitted data for 2016 secondary breast cancer diagnoses through the Cancer Outcomes and Services Dataset or Cancer Waiting Times data collection mechanisms. The total number submitted was 11,608, which is an increase on 2014 and 2015. This is accepted as being significantly below the estimated number of secondary breast cancers.</p><p> </p><p>The National Cancer Registration and Analysis Service (NCRAS) has published a number of guidance documents including flowcharts and clearer data definitions, providing specific advice on how to record cancer patients who are on a non-primary pathway. NCRAS is visiting trusts to support the use of this guidance.</p><p> </p><p>NCRAS is working closely with cancer charities to improve data collection and submission by hospital trusts, looking at how they can help improve completion rates and thus gain a better picture of the burden of recurrence and metastatic disease across the health service.</p><p> </p><p>To further support this work NCRAS has been sharing provider-level data on the completeness of recurrence reporting with individual NHS trusts since July 2016. These data are publicly available at the following link:</p><p> </p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 184979 question first answered 06/11/2018 15:35:08 answering member 4067 label Biography information for Steve Brine
	tabling member	4056 label Biography information for Nic Dakin

997158

	registered interest
	date	29/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure hospital trusts meet the requirement to (a) collect and (b) submit data on secondary breast cancer.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	184979
	answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>140 hospital trusts submitted data for 2016 secondary breast cancer diagnoses through the Cancer Outcomes and Services Dataset or Cancer Waiting Times data collection mechanisms. The total number submitted was 11,608, which is an increase on 2014 and 2015. This is accepted as being significantly below the estimated number of secondary breast cancers.</p><p> </p><p>The National Cancer Registration and Analysis Service (NCRAS) has published a number of guidance documents including flowcharts and clearer data definitions, providing specific advice on how to record cancer patients who are on a non-primary pathway. NCRAS is visiting trusts to support the use of this guidance.</p><p> </p><p>NCRAS is working closely with cancer charities to improve data collection and submission by hospital trusts, looking at how they can help improve completion rates and thus gain a better picture of the burden of recurrence and metastatic disease across the health service.</p><p> </p><p>To further support this work NCRAS has been sharing provider-level data on the completeness of recurrence reporting with individual NHS trusts since July 2016. These data are publicly available at the following link:</p><p> </p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 184978 question first answered 06/11/2018 15:35:09 answering member 4067 label Biography information for Steve Brine
	tabling member	4056 label Biography information for Nic Dakin

922498

	registered interest
	date	12/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	22q11.2 Deletion Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to improve (a) awareness of and (b) diagnosis of 22Q11 deletion syndrome.
	tabling member constituency	Oxford West and Abingdon
	tabling member printed	Layla Moran
	uin	152852
	answer	answer is ministerial correction date of answer 15/06/2018 answer text <p>22q11.2 deletion syndrome is a disorder that involves many different areas of the body and the severity can vary among patients. 22q11.2 deletion syndrome is an integral part of the immunodeficiency section of the training curriculum for paediatric and adult immunologists. In addition, cardiac aspects of 22q deletion syndrome are specifically included in the curriculum for paediatric cardiology.</p><p> </p><p>There are 32 immunology centres accredited or working towards accreditation with the Quality in Primary Immunodeficiency Services programme including a number of paediatric immunology centres located across the United Kingdom, which provide services for patients affected by the disease. Such accreditation processes means that specialist expertise can be more readily available across the country and provide access to the services need in the diagnosis of this disease.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/06/2018 14:49:29 answering member 4067 label Biography information for Steve Brine
	tabling member	4656 label Biography information for Layla Moran

1046125

	registered interest
	date	22/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of generic drugs his Department is currently paying a premium for due to shortage of supply.
	tabling member constituency	Vauxhall
	tabling member printed	Kate Hoey
	uin	211090
	answer	answer is ministerial correction date of answer 30/01/2019 answer text <p>30 concessionary prices have been granted so far for the month of January. However, we are still considering requests from the Pharmaceutical Services Negotiating Committee for January. The concessionary prices granted for each month can be found on the website of the NHS Business Services Authority.</p><p> </p><p>In primary care, concessionary prices ensure that patients continue to get their medication and community pharmacists are reimbursed fairly if the price of a generic medicine suddenly increases and community pharmacies cannot purchase the medicine at the price listed in the Drug Tariff. The sudden increase in a price may be the consequence of a supply issue but may have other causes including normal market forces leading to prices going up. Concessionary prices are granted for one month.</p><p> </p><p>Whilst a supply issue may lead to a price increase and therefore a concessionary price, the number of concessionary prices granted is not an indication of the number of medicines supply issues.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 211091 question first answered 30/01/2019 17:16:46 answering member 4067 label Biography information for Steve Brine
	tabling member	210 label Biography information for Baroness Hoey

1046126

	registered interest
	date	22/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the implications for his policies of recent trends in the shortage of supply for drugs; and if he will make a statement.
	tabling member constituency	Vauxhall
	tabling member printed	Kate Hoey
	uin	211091
	answer	answer is ministerial correction date of answer 30/01/2019 answer text <p>30 concessionary prices have been granted so far for the month of January. However, we are still considering requests from the Pharmaceutical Services Negotiating Committee for January. The concessionary prices granted for each month can be found on the website of the NHS Business Services Authority.</p><p> </p><p>In primary care, concessionary prices ensure that patients continue to get their medication and community pharmacists are reimbursed fairly if the price of a generic medicine suddenly increases and community pharmacies cannot purchase the medicine at the price listed in the Drug Tariff. The sudden increase in a price may be the consequence of a supply issue but may have other causes including normal market forces leading to prices going up. Concessionary prices are granted for one month.</p><p> </p><p>Whilst a supply issue may lead to a price increase and therefore a concessionary price, the number of concessionary prices granted is not an indication of the number of medicines supply issues.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 211090 question first answered 30/01/2019 17:16:46 answering member 4067 label Biography information for Steve Brine
	tabling member	210 label Biography information for Baroness Hoey

943886

	registered interest
	date	18/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Veterinary Medicine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the answer of 17 July 2018 to Question 161987 on Veterinary Medicine, how many veterinary surgeons from (a) non-UK EU and (b) non-EU member states employed by organisations contracted to deliver veterinary services in abattoirs on behalf of the by Food Standards Agency, have left that employment since 23 June 2016; and if he will make a statement.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	165449
	answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>339 non-United Kingdom European Union veterinary surgeons employed by organisations contracted to deliver veterinary services in abattoirs on behalf of the Food Standards Agency, have left that employment since 23 June 2016.</p><p> </p><p>One non-EU veterinary surgeon employed by organisations contracted to deliver veterinary services in abattoirs on behalf of the Food Standards Agency, has left that employment since 23 June 2016.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/07/2018 14:57:20 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

1082309

	registered interest
	date	05/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many children aged (a) four to five and (b) 10 to 11 years were recorded as obese in (i) England, (ii) each English region and (iii) each London borough in each year since 2010-11.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	228739
	answer	answer is ministerial correction date of answer 13/03/2019 answer text <p><strong></strong>Data on the number of children recorded as obese in England, each region and each London Borough aged four to five years and aged 10 to 11 years, are attached.</p> answering member constituency Winchester answering member printed Steve Brine attachment 1 file name Table 1_Number of children aged 4-5 years measured in the National Child Measurement Programme (NCMP) in the obese category.docx title PQ228739 attached table 2 file name Table 2_Number of children aged 10-11 years measured in the National Child Measurement Programme (NCMP) in the obese category.docx title PQ228739 attached table question first answered 13/03/2019 12:32:22 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

1081713

	registered interest
	date	04/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the reasons why uptake rates among groups eligible for the free influenza vaccine are low.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	228005
	answer	answer is ministerial correction date of answer 12/03/2019 answer text <p><strong></strong>Provisional data for flu season 2018-19 (autumn to spring) shows that flu vaccine uptake in those aged 65 and over is at similar levels to previous years and close to the World Health Organization target of 75%.</p><p> </p><p>Vaccine uptake in the children’s programme is at the highest level since the introduction of the programme for two and three-year olds vaccinated in general practice and for children offered the vaccine in primary school.</p><p> </p><p>For pregnant women and for those in at risk groups eligible for flu vaccine, the vaccination uptake is slightly lower compared to last year. There are many reasons for this. Many patients do not appreciate how serious flu can be and the importance of protecting themselves.</p><p> </p><p>Provisional data can be viewed at the following link:</p><p> </p><p><a href="http://www.gov.uk/government/collections/vaccine-uptake" target="_blank">www.gov.uk/government/collections/vaccine-uptake</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/03/2019 16:22:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

1062039

	registered interest
	date	15/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to page 14 of the National Audit Report entitled Investigation into the management of health screening, published 30 January 2019, for what reasons the project to replace the National Health Application and Infrastructure Services is 22 months behind schedule.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	221993
	answer	answer is ministerial correction date of answer 20/02/2019 answer text <p><strong></strong>The priority for NHS England has been to ensure that Capita provide a service that is stable and delivering safely for patients before the change takes place. Early service delivery issues in Primary Care Services England together with recent screening incidents have been the priority to ensure patient safety. The change required to remove the use of National Health Application and Infrastructure Services (NHAIS) is complex due to the aged architecture and local variations in how data is stored on each individual NHAIS database and the sensitivity of that information.</p><p> </p><p>In the meantime, NHS England has asked Sir Mike Richards to lead a review to improve the delivery of adult screening programmes, and will consider how current IT systems support the ambitions of the programmes.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/02/2019 17:37:17 answering member 4067 label Biography information for Steve Brine
	tabling member	4036 label Biography information for Luciana Berger